Supreme Court extends access to abortion pill by mail
The Supreme Court has temporarily allowed continued access to the abortion pill mifepristone while reviewing a legal challenge. This decision affects the availability of the medication through telemedicine and mail. (sources: nbcnews, theguardian, npr, abcnews, thehill)
The Supreme Court has extended access to mifepristone for at least three more days as it considers a case that may impact the drug's availability. This follows a provisional block of a lower court ruling that sought to restrict access.
- The Supreme Court has temporarily allowed full access to mifepristone while reviewing a legal challenge.
- The extension includes access through telemedicine and mail.
- The current extension lasts for at least three more days.
Why it matters
The decision affects the ongoing legal landscape surrounding access to abortion medication in the United States.
↓ Why this is on ModernAction
5 bills on this issue are moving right now — and the most active one is Stop Comstock Act.
S951 · 119th Congress
Stop Comstock Act
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What S951 actually does
This story is about Supreme Court extends access to abortion pill by mail. This bill would The legal fight over mifepristone-by-mail often turns on whether old federal “mailing”/“importation” restrictions would be used to block shipp.
If passed, it would:
- Change federal criminal/shipping-law language that would be invoked to target mailing items “for procuring abortion • Reduce legal uncertainty for pharmacies, providers, and carriers around mailing abortion-related drugs/items across.
4 other bills moving on this issue
Take action on any of them individually.
This story is about Supreme Court extends access to abortion pill by mail. This bill would constrain FDA actions on abortion-drug approvals/labeling and add prescriber/dispensing requirements.
If passed, it would
- Constrain FDA actions on abortion-drug approvals/labeling and add prescriber/dispensing requirements • Reduce/limit mail-based access by requiring in-person administration for previously approved abortion drugs.
This story is about Supreme Court extends access to abortion pill by mail. This bill would nullify the January 2023 REMS modifications and bar similar future changes.
If passed, it would
- Nullify the January 2023 REMS modifications and bar similar future changes • Push mifepristone dispensing back toward in-person channels, affecting mail distribution.
This story is about Supreme Court extends access to abortion pill by mail. This bill would If courts or states restrict access to mifepristone (an FDA-approved drug), this bill is framed to protect individuals’ ability to access FD.
If passed, it would
- Create a federal statutory right to obtain FDA-approved medicines and a corresponding right for providers to provide • Limit federal/state enforcement of rules that restrict the sale/provision/use of FDA-approved medicines.
This story is about Supreme Court extends access to abortion pill by mail. This bill would If mifepristone remains available by mail/telemedicine, this bill would restrict telehealth medication-abortion practice nationally by requi.
If passed, it would
- Require physical exam and physical presence for “chemical abortions • Reduce or eliminate mail-based telemedicine models for medication abortion (subject to the bill’s exception language.
Top coverage · 11 sources